Did you miss any of our patient week sessions? Take a look at this report for what happened during our inaugural PMF Patient Week 2021.
Dr. Euan Ashley, of Stanford University, speaks about the work he’s done with genome sequencing, and genetic testing and data.
Prof Dr Ingemar Ernberg, Professor at Karolinska Institutet, joined us on February 11, 2021
Zoe Martin, Policy Manager, of Cancer Research UK, joined our panel discussion on February 11, 2021
Dr. Sheuli Porkess, Interim Medical Director, of The Association of the British Pharmaceutical Industry (ABPI) joined us on February 11, 2021
Dr Åslaug Helland, of Oslo University Hospital, joined us for our panel discussion on February 4 to discuss, ‘Innovative Clinical Trial Design for Precision Oncology’
Penilla Gunther, of FOKUS Patient joined us for our Virtual Panel Series discussion on February 4.
Dr. Razelle Kurzrock, of UCSD Moores Cancer Center and University of California San Diego School of Medicine
Dany Bell, of Macmillan Cancer Support spoke to us about the work she does at Macmillan Cancer Support.
Tamara Hussong Milagre, of EVITA, joined us for an interview to discuss her personal family history with cancer, her organisation.
Miriam Döbeli, of COLORECTUM, joined us to discuss the backstory of her role within patient advocacy…
Peter Kapitein, of Inspire2Live, joined us for a short interview to talk about the organisation and our upcoming event PMF Patient Week 2021.
During our Virtual Panel Series discussion on January 13th, Dr. Marjut Salokannel docent joined us to discuss the topic…
During our Virtual Panel Series discussion on January 13th, Dr. Ana Nordberg joined us to discuss the topic…
During our Virtual Panel Series discussion on January 13th, Dr. Mahsa Shabani joined us to discuss…
Prof Kjetil Tasken speaks about CAR T-cells therapy and inequalities in cancer treatment
Prof. Magnus Essand, of Uppsala University, joined us for our Virtual Panel Discussion on December 17th.
During our Virtual Panel Series discussion on December 17th, our expert panellist’s discussed, Immuno-oncology….
Prof. Rob Jones, of Cancer Research UK Glasgow Clinical Trials Unit, speaks about the next steps that need to be taken for clinical trials to progress
Dr. Capucine Baldini, of Gustave Roussy, speaks about how Gustave Roussy dealt with the first and second waves of the pandemic.
Eibhlin Mulroe spoke to PMF about the difficulties of performing clinical trials in hospitals during the first and second wave of the pandemic.
Dr Capucine Baldini, Medical Oncologist, Drug Development (DITEP), Institut de Cancérologie Gustave Roussy, will be joining us for our next Virtual Panel Series
Prof. Rob Jones gives us insight into the work being done at Cancer Research UK Glasgow Clinical Trials Unit
Dr. Julien Masliah Planchon, of Institut Curie, gave interesting insight into Institut Curie’s use of Molecular Tumour Boards.
Dr. Maud Kamal, of Institut Curie, joined us for our Virtual Panel Series discussions on November 12, 2020
Our panelist’s delved into the topic of data integrity and how important it is in today’s research and healthcare settings.
In this clip from our Virtual Panel Series session on November 12, 2020, Dr. David Tamborero, of Karolinska Institutet, answered an audience question…
Director of Precision Medicine Forum, Steve Coldicott, realised that there was a need for researchers to be able to share their scientific posters online.
In this clip from our Virtual Panel Series discussion on October 22, 11am EST, Dr. Maurie Markman, talks about the role science plays in encouraging patients to return to hospitals.
Dorothy Erlanger, Chair of the Patient Advocate Committee at the National Cancer Institute, spoke about the difficulties facing patient treatment during the pandemic.
During our Virtual Panel Series discussion on October 22 at 11am EST, we got the perspective of how the pandemic is being dealt with in the US.
For our first Virtual Panel Series session, our expert panellist’s were discussing the impact Covid-19 has had on Cancer treatment and screening.
During our first Virtual Panel Series Discussion on October 22, 2020, our expert panellist’s were speaking about the impact Covid-19 has had on cancer treatment and screening.
The University of Oxford Partners with King Abdulaziz University to set up a new Centre for Artificial Intelligence and Precision MedicineView Post
UK Government launches NEW National Genomics Healthcare StrategyView Post
Pricey Precision Medicine Often Financially Toxic For Cancer PatientsView Post
YOU CAN’T HELP EVERYBODY BUT YOU CAN MAKE SURE YOU HELP THE RIGHT PEOPLEView Post
TO LIVE TOGETHER IS THE ESSENCE OF LIFEView Post
EVERY PATIENT IS UNIQUEView Post
THERE IS NO PRECISION MEDICINE WITHOUT COLLABORATIONView Post
PRECISION MEDICINE SHOULD BECOME NORMAL TO IMPLEMENT IN PRIMARY CARE PRACTICEView Post
WE NEED TO BREAK DOWN THE BARRIERS THAT ARE HOLDING BACK INNOVATIONView Post
DATA ANALYSIS, AGGREGATION AND MANAGEMENT HAVE AN ESSENTIAL ROLE TO PLAY IN GAINING INSIGHTS AND WISDOM FROM GENOMIC DATAView Post
To help patients is the goal of everythingView Post
IT’S ALL ABOUT COLLABORATION – ALONE WE CAN’T DO ANYTHINGView Post
Precision medicine and what it means to be humanView Post
Sweden’s strong tradition in genetic technologyView Post
Pharmacogenetics the Dutch wayView Post
We need to change our expectationsView Post
Published on May 31, 2016 At Roche Pharma Research and Early Development, we are working on a novel form of engineered antibodies for cancer immunotherapy that we call T-cell bispecific antibodies. We consider them match-makers between T-Cells and cancer cells. With two handles, they recognize specific markers on the surface of cancer cells. A third handle is designed to hook …
- Page 1 of 2